Aortic Stenosis Market Report 2025 (Global Edition)

Global Aortic Stenosis Market Report 2025 Market Size Split by Type (Acquired Aortic Stenosis, Congenital Aortic Stenosis), by End User (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), by Therap...

Aortic Stenosis Market Report Description

We have various report editions of Aortic Stenosis Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Aortic Stenosis Market Insights Video

Competitive Landscape of Aortic Stenosis

Few major companies, including Edwards Lifesciences Corporation, CryoLife Inc., LivaNova PLC, and Medtronic plc, dominate the consolidated worldwide aortic valve market. Major competitors in the aortic valve sector have recently implemented a number of tactical tactics, such as product releases and successfully pursuing approvals from numerous health organizations throughout the world, to obtain an advantage in the market. 

September 2019: The FDA-approved Evolut PRO+ TAVR system was launched in the US by Medtronic plc. With the reduced delivery profile and increased surface area engagement among the valve and the native aortic annulus offered by the Evolut PRO+ TAVR system, valve sealing performance is significantly improved.

(Source:www.accessdata.fda.gov/cdrh_docs/pdf13/P130021S058d.pdf)

June 2020: Edwards Lifesciences Corporation reported that the Edwards SAPIEN 3 transcatheter heart valve has been given Chinese regulatory approval for the treatment of patients with severe, symptomatic aortic stenosis (AS) who are unable to have open-heart operations or for whom such invasive procedures are deemed to be extremely risky.

(Source:www.edwards.com/newsroom/news/2020-06-08-edwards-sapien-3-transcatheter-heart-valve-receive-a4c306b)

Top Companies Market Share in Aortic Stenosis Industry: (In no particular order of Rank)

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• LivaNova PLC
• Edwards Lifesciences Corporation
• CryoLife Inc.
• JenaValve Technology Inc.
• Thubrikar Aortic Valve
• LifeNet Health
• Coroneo
• Meril Life Sciences Pvt. Ltd.
• AstraZeneca plc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, North America Aortic Stenosis Market share was 35% of total market

In 2022, North America controlled the market and brought in more than 35% of worldwide revenue, according to Cognitive Market Research. Aortic Stenosis is the most popular condition in North America. Due to the presence of large players, a developed healthcare sector, and advancements in TAVI valve technology in the region, During the anticipated time, North America is expected to continue to dominate the transcatheter aortic valve implantation market, which it did in 2020. The rise in high-risk patients, the prevalence of severe aortic stenosis cases, and increased patient and physician awareness of the availability of cutting-edge transcatheter aortic valves are all factors contributing to the growth of the North American TAVI market. Additionally, favourable reimbursement practises in several American countries are essential for this region to adopt TAVI operations more frequently.

The market for aortic valves in the North American region was dominated by Europe. This is mostly caused by the region's growing geriatric population, expensive healthcare spending, and rising rates of chronic and lifestyle-related disorders. The large frequency of aortic stenosis, the development of efficient treatments like transcatheter aortic valve replacement (TAVR), and the expansion of programmes to raise public knowledge of valve replacement surgeries are some additional essential characteristics of the European market.

The current report Scope analyzes Aortic Stenosis Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

Aortic Stenosis Market Analysis

Type Segment Analysis

Acquired aortic stenosis held the largest market share in this category. Exertion-induced dyspnea, syncope, angina, and finally heart failure are symptoms of acquired aortic stenosis. Patients with a bicuspid aortic valve typically experience signs among the ages of 50 and 70, while those with calcific stenosis of the tri-leaflet valve typically experience symptoms after the age of 70. 

The fastest-growing subset of this section is congenital aortic stenosis. Bicuspid aortic valves, which have two cusps rather than three (tricuspid aortic valves), are sometimes present in newborns. Aortic valves with one (unicuspid) or four (quadricuspid) cusps are extremely rare. A congenital cardiac defect called a bicuspid aortic valve calls for regular medical checks. The valve issue might not become problematic until adulthood. The valve could need to be fixed or replaced if it starts to narrow or leak.

• Acquired Aortic Stenosis
• Congenital Aortic Stenosis

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Aortic Stenosis Industry. Request a Free Sample PDF!

End User Segment Analysis

The market share that the hospital pharmacy sector accounted for was the highest. Patients with aortic stenosis typically receive their healthcare in hospital pharmacies since these operations call for specialized facilities and tools. They are the perfect location for aortic valve replacement surgeries since they feature the newest medical equipment and highly skilled medical personnel.

The fastest expanding industry in this area is online pharmacies. It is very easy to buy prescription drugs from an online pharmacy. For those who live far from a regular pharmacy, are elderly, disabled, or work really hard, this method is a very quick and easy way to receive medication.

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Aortic Stenosis Therapeutic Drug Segment Analysis

The Therapeutic Drug segment's greatest shareholder is a diuretic. Diuretics are medications that aid in reducing the body's fluid retention. They are referred to as water pills at times. The majority of diuretics aid kidneys in eliminating water and salt through urine. As a result, less fluid passes through the veins and arteries. Consequently, blood pressure decreases.

Cardiac glycosides are drugs used to treat certain irregular heartbeats and heart failure and are the fastest growing sector in this segment. They are one of many medication types used to treat problems relating to the heart and other organs. These drugs frequently lead to poisoning. Numerous plants, notably the leaves of the digitalis (foxglove) plant, contain cardiac glycosides. The initial source of this medication was this plant. When these leaves are consumed in significant quantities, people may experience overdose symptoms.

• Diuretics
• Angiotensin Converting Enzyme Inhibitors
• Beta – Blockers
• Cardiac Glycosides
• Transcatheter Aortic Valve
• Sutureless Valve

Aortic Stenosis Route of Administration Segment Analysis

The main shareholder in this sector is Implant. An implant is a medical device created to replace a missing biological structure, sustain a broken biological structure, or improve an already existent biological structure. An implant might be a rod, for instance, which is used to reinforce brittle bones. 

In this market, parenteral is expanding at the fastest rate. Drugs administered via routes other than the digestive tract are referred to as parenteral medication administration. Parenteral refers to medications administered via injection or infusion. The term "enteral route" typically refers to ingesting medication. At some point during their stay, the majority of hospital patients get parenteral medications. Additionally becoming more prevalent in the population is the usage of parenteral drugs.

• Oral
• Parenteral
• Implants

Aortic Stenosis Distribution Channel Segment Analysis

When it comes to Distribution Channel, the online sector holds the most shares. Time savings is one of the E-Pharmacy application's key benefits. You may simply get your medication online and receive your prescription medications. Simply insert the prescription into the mobile application or website to place an order.

Regarding Distribution Channel, the offline sector is the one that is expanding the quickest. While going to a store to buy medication may be a hassle for some individuals, the sector in this market is being driven by the fact that customers may speak openly with a counsellor when they visit a store. 

• Offline
• Online

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion